BUDA logo

BUDA JUICE INC

BUDANYSE AMERICAN
πŸ† #3059 by market capEarnings Aug 13US Equity
$916.27β–Ό $11.18 (βˆ’1.22%)
Simulated price
1hβ€”
24hβ–Ό 1.2%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$107M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+0.0%
Slowing
πŸ“ŠGross Margin
40.4%
Healthy
πŸ’΅FCF Margin
17.1%
Healthy
βš–οΈP/S Ratio
11.2x
Elevated
Otter Score
52
Weak
No chart data available for BUDA.

Trading Snapshot

Day Range
$908.76 – $926.47
52-Week Range
$6.25 – $12.00
Volume
$3.64B
Avg Volume
$3.07B
Shares Outstanding
12.6M
Next Earnings
Sep 24, 2026

Fundamentals Snapshot

Annual Revenue
$13M
Last Q Revenue
$4M
P/E Ratio
55.1
P/S Ratio
11.2x
EPS (TTM)
$0.15
Dividend Yield
0.00%

Why Investors Own BUDA

  • βœ“High-growth profile β€” revenue up -5.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 54% gross margin and 26% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$13Mβ–Ό βˆ’6.5% YoY
Gross Margin (TTM)
54.4%β–² +1.2% YoY
Operating Income (TTM)
$3Mβ–Ό βˆ’6.5% YoY
Free Cash Flow (TTM)
$3Mβ–Ό βˆ’6.5% YoY

About BUDA JUICE INC

Established in 2013, Buda Juice is a Dallas, Texas-based enterprise specializing in the creation and distribution of organic, cold-pressed beverages. The company's offerings, all USDA-certified organic and crafted from fresh fruits and vegetables, are exclusively bottled in glass. Beyond its core juice lines, Buda Juice provides diverse products including one-to-five-day juice cleanse programs, bulk packs of ginger and turmeric shots, and a selection of citrus-based Buda Zen brand juices. Additionally, their range encompasses organic soups and various plant-based milk alternatives. To ensure optimal quality and freshness, every item is meticulously kept refrigerated from its production through to the point of sale. Buda Juice primarily serves wholesale clients.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$1,123.76
β–² +22.6% Upside
High Target$1,236.50
Low Target$961.18
Based on 28 analysts

Latest News & Updates